ARTICLE |
Correspondence to: Constance Oliver, Faculdade de Medicina de Ribeirão Preto, Depto. Morfologia, Av. Bandeirantes 3900, 14049-900 Ribeirão Preto, SP, Brasil. E-mail: coliver@rmf.fmrp.usp.br
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Previous studies of mast cell maturation, structure, and function have been hampered by the lack of mast cell-specific markers. In this study, using a well-characterized mast cell-specific monoclonal antibody, MAb AA4, mast cells from rat bone marrow in various stages of maturation were isolated and characterized. The very immature mast cells, which have not been previously described, contained few granules and would not be recognized as mast cells by standard cytological methods. Pure populations of mast cells were isolated from the bone marrow using MAb AA4-conjugated magnetic beads. The same stages of maturation were observed in the isolated mast cells as were seen in the unfractionated bone marrow. All of these cells were immunopositive for the -subunit of Fc
RI, IgE, and c-kit, confirming their identity as mast cells. By direct counting of immunolabled cells and by flow cytometry, approximately 2.4% of the cells in the bone marrow are mast cells. Staining with toluidine blue and berberine sulfate, as well as RT-PCR of the cells, indicates that these cells are connective tissue-type mast cells. The use of immunological methods for identification of mast cell precursors should facilitate the study of these cells. (J Histochem Cytochem 49:219228, 2001)
Key Words: mast cells, gangliosides, maturation, bone marrow, immunochemistry, rat
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
MAST CELLS play a critical role in inflammatory and allergic reactions, and contribute to host resistance to parasites (
The MAb AA4 was originally identified as one of several monoclonal antibodies raised against the surface of RBL-2H3 cells that affect histamine release (RI and co-precipatate with the Src family tyrosine kinase p53/56lyn (
RI, but without the release of histamine (
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cells
Young (150 g) male and female Wistar (Secretary of Health; Paraná State, Paraná, Brazil) and SpragueDawley (Harlan SpragueDawley; Indianapolis, IN) rats were used. Animals were housed and experiments were conducted according to NIH guidelines. Bone marrow from the femurs of the rats was removed with Dulbecco's PBS containing heparin (1000 U/ml; Produtos Roche Químicos e Farmacêuticos, Rio de Janeiro, Brazil) and DNase (1000 U/ml, Type I; Sigma Chemical, St Louis, MO). The cells were dissociated by aspiration with a Pasteur pipette. They were then rinsed twice by centrifugation (27 x g) in PBS.
Peripheral blood was collected in a heparinized syringe by cardiac puncture.
Peritoneal cells were obtained by injecting rats IP with 15 ml PBS. The peritoneal wash was collected with a Pasteur pipette after laparotomy. The cells were rinsed twice by centrifugation (27 x g) in PBS and placed on Cell Tak (Becton Dickinson Labware; Collaborative Biomedical Products, Bedford, MA)-coated coverslips. In some experiments, the adherent cells were separated from non-adherent cells by resuspending the cells in PBS + 1% BSA, allowing them to settle onto an uncoated coverslip for 1 h at 37C, and then rinsing the coverslip three times in PBS.
Antibodies
MAbs AA4 and BC4 (1.
Coupling of Antibody to Magnetic Beads
MAb AA4 was conjugated to tosylactivated Dynabeads (Dynal; Lake Success, NY) as previously described (
Cell Separation
The cells were incubated with coated beads (3 beads/target cell) in PBS containing 2% BSA for 510 min at room temperature (RT). After incubation the mast cells were isolated by washing four times with PBS containing 2% BSA and once in PBS.
Light Microscopy
Cells were rinsed in PBS and placed on coverslips coated with Cell Tak (Becton Dickinson Labware). Some samples were fixed and stained with Toluidine Blue (4% formaldehyde, 0.1% Toluidine blue, and 1% acetic acid, pH 2.8, for 10 min) or Alcian Blue (1% Alcian Blue in 0.1 N hydrochloric acid for 30 min). Other samples were fixed with 4% formaldehyde for 20 min and stained with 0.02% berberine sulfate (Molecular Probes; Eugene, OR), pH 4.0, for 20 min, rinsed in water adjusted to pH 4.0 with acetic acid for 5 min, and mounted in anhydrous glycerol. For immunostaining of plastic-embedded samples, tissues from 250-g male SpragueDawley rats were fixed for 2 hr in 4% formaldehyde, dehydrated and embedded in JB-4 plastic (EM Sciences; Fort Washington, PA). Four-µm sections were mounted on glass slides and the sections treated with xylene for 15 min and then rehydrated to water. The sections were blocked with 1% BSA in PBS and incubated with MAb AA4 for 2 hr at 37C. After rinsing in PBS, the sections were treated with AuroProbe LM gold-conjugated goat anti-mouse IgG (Amersham Pharmacia Biotech; Uppsala, Sweden), and the gold silver enhanced (IntenSe M; Amersham Pharmacia). For fluorescence microscopy, cells were placed on Cell Tak-coated coverslips, rinsed three times in PBS, and fixed and permeabilized in 2% formaldehyde (EM Sciences) in methanol for 5 min at -20C. The cells were rinsed in PBS, PBS containing 0.1 M glycine, and incubated with MAb AA4 (5 µg/ml) directly conjugated to FITC or anti c-kit (10 µg/ml) for 1 hr at RT. After incubation, the cells were rinsed thoroughly in PBS and the samples incubated with anti c-kit were further incubated with donkey anti-rabbit Fab'2 conjugated to FITC (JacksonImmunoResearch; West Grove, PA). All cells were then rinsed and the coverslips mounted with Fluoromount-G (EM Sciences) and observed with fluorescence and phase-contrast microscopy.
Electron Microscopy
For routine electron microscopy, cells were fixed in 2% glutaraldehyde (Ladd Research Industries; Burlington, VT)2% paraformaldehyde (Ladd) in 0.1 M cacodylate buffer, pH 7.4, containing 0.05% CaCl2, for 40 min at RT.
Because all of the antigens detected are sensitive to glutaraldehyde, for immunoelectron microscopy the samples were fixed by microwave. Cells were suspended in 5 ml of fixative containing 2% formaldehyde, 0.05% glutaraldehyde (Ladd), 0.025% CaCl2 in 0.1M cacodylate buffer, pH 7.4, and irradiated for 4 sec at 100% power (
After fixation, cells were incubated with primary antibody (MAb AA4, 2.5 µg/ml; MAb BC4, 0.5 µg/ml; anti-IgE, 5 µg/ml) diluted in PBS + 1% BSA for 1 hr at RT. After incubation the cells were rinsed sequentially in PBS + 1% BSA, PBS, PBS + 1% BSA, and then incubated for 1 hr with donkey anti-mouse IgG conjugated to horseradish peroxidase diluted (25 µg/ml final concentration; Jackson ImmunoResearch) in PBS + 1% BSA. Cells incubated without primary antibody or with normal mouse IgG (5 µg/ml; Jackson ImmunoResearch) in place of the primary antibody served as controls. None of the controls was immunolabeled. The cells were then rinsed in PBS + 1% BSA, PBS and 0.1 M cacodylate buffer (pH 7.4) and immersed in diaminobenzidine incubation medium [12.5 ml cacodylate buffer, 12.5 mg diaminobenzidine (Polysciences; Warrington, PA) and 250 µl 1% H2O2] for 30 min at RT. The cells were then rinsed 10 times in cacodylate buffer. For light microscopy, endogenous peroxidase was blocked by incubating the samples for 30 min in 3% H2O2 in methanol at RT. Some samples were packed by centrifugation in 1.5% agar before processing for electron microscopy. Cells were postfixed in 2% OsO4 (EM Sciences) for 1 hr at RT, rinsed in distilled water, dehydrated through a graded series of ethanols, rinsed in acetone, and embedded in Embed 812 (EM Sciences). Thin sections were cut with a diamond knife and stained for 10 min each in Reynolds'lead citrate (
Flow Cytometry
The suspension of bone marrow cells was washed twice by centrifugation (27 x g) in PBS + 2% BSA, blocked for 1 hr with rat IgG (5 µg/ml), rinsed in PBS + 2% BSA, and incubated with MAb AA4 directly conjugated to FITC (2.5 µg/ml; filtered through a 0.22 µm Millex-GV filter unit; Millipore Products Division, Bedford, MA) in PBS + 1% BSA for 1 hr at RT or with rabbit IgG directly conjugated to FITC (3 µg/ml, filtered through a 0.22 µm Millex-GV filter unit). After incubation, the cells were washed five times in PBS + 1% BSA and analyzed with a Becton-Dickinson Fluorescence Activated Cell Sorter (Becton-Dickinson Labware; Bedford, MA) using the Lysis II program. Because the bone marrow-derived mast cells do not represent a homogeneous population, the area to be gated was determined by sorting the cells inside the gate and examining the sorted cells by fluorescence microscopy. The gate was set to exclude any debris less than 2.5 µm in diameter and above cells displaying autofluorescence.
Cell Counts
The percentage of mast cells present in the bone marrow was determined by counting, in a Neubauer Camera, the positive and negative cells after immunostaining with either MAb AA4 or anti-IgE, and by counting the number of cells that were either free or attached to MAb AA4-conjugated beads.
The percentage of isolated cells that immunolabeled with MAb AA4, MAb BC4, anti-IgE, or anti-c-kit was determined by counting five separate fields from five different experiments with a x 40 objective. A minimum of 1000 cells/antibody was counted.
Cell Measurements
Cell volume was calculated from measurements of cell diameter of cells isolated with and attached to MAb-AA4-conjugated beads. A total of 150 cells were measured, with a minimum of 25 cells for each stage of maturation. Measurements were made by light microscopy of Toluidine Blue-stained preparations and were compared with measurements from electron micrographs of cells that were positive after immunostaining. Because of potential errors induced by measuring thin sections of cells, all data reported here are from whole cells measured by light microscopy.
RT-PCR
RNA was extracted from rat bone marrow cells and MAb AA4-isolated cells using the RNeasy Mini Kit (Quiagen; Valencia, CA). The RNA was treated with DNase I to eliminate residual genomic DNA; cDNA was then synthesized with the SUPERSCRIPT preamplification system for first strand cDNA synthesis (GIBCO-BRL; Grand Island, NY) and reverse-transcribed using random hexamer primers. Six pairs of oligonucleotide primers (Life Technologies; Rockville, MD) were used for amplification for 30 sec at 94C, 30 sec at 55C, and 1 min at 72C for 35 cycles in a 25-µl reaction, using Platinum Taq Polymerase (GIBCO-BRL). The PCR products were analyzed on 2.5% agarose gels.
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Mature and immature mast cells from rat bone marrow were identified and isolated using the mast cell-specific antibody MAb AA4. The specificity of MAb AA4 for mast cells was reconfirmed by immunostaining 18 different tissues from the rat: adrenal gland, brain, duodenum, epididymis, heart, kidney, lacrimal gland, liver, lung, parotid gland, pancreas, skeletal muscle, skin, spleen, sublingual gland, submandibular gland, testis, and thymus. After immunostaining, the mast cells were further identified by staining the sections with either Alcian Blue or Toluidine Blue (Fig 1A) Only mast cells were immunolabeled in all of the tissues examined. No other cell type was labeled. All controls were negative. In addition, rat whole peripheral blood smears and cells from peritoneal washings were immunostained with MAb AA4. In the peripheral blood, no cells were stained with MAb AA4 and, as expected (
|
|
Although mast cell maturation is a dynamic process, on the basis of cell size, granule content, and overall morphology mast cells in three distinct stages could be distinguished among the immunolabled cells: very immature, immature, and mature. The mature mast cells could be readily identified on the basis of their morphology alone. However, the immature and very immature mast cells could not be identified without the use of the mast cell-specific antibody MAb AA4 (Fig 3). The very immature cells (Fig 3A) had large nuclei and the cytoplasm was virtually devoid of organelles other than mitochondria. A few small granules, usually less than three per section, could be found in the cytoplasm. The most prominent features of the immature mast cells (Fig 3B and Fig 3C) were a well-developed Golgi apparatus and many electron-dense granules of various sizes in the cytoplasm. These cells appeared to be actively forming cytoplasmic granules, with the number of granules increasing as the cells matured. In addition, the nucleus was concave and often peripherally located. The mature mast cells (Fig 3D) displayed morphology typical for these cells. They contained a centrally located spherical nucleus, a cytoplasm filled with characteristic dense granules, and few organelles. Analysis of the total cell population from the bone marrow by flow cytometry using MAb AA4 to immunolabel the mast cells showed that only 2.34 ± 0.5% of the cells in the bone marrow are mast cells. Fig 4 shows the results of a representative experiment. By light microscopy, the number of mast cells present in the bone marrow was 2.4 ± 0.6%. This is in agreement with the percentage obtained by FACS analysis. Because the mast cells make up only a small proportion of the cells in bone marrow, we were concerned that, because of problems in sampling a specimen by electron microscopy, some stages of mast cell maturation could be missed by immunolabeling the whole cell population. Therefore, MAb AA4 was coupled to magnetic beads and the mast cells were isolated by immunomagnetic separation (-subunit of the high-affinity IgE receptor (
|
|
|
|
|
Light microscopic measurements of immunomagnetically isolated mast cells showed that, as the mast cells matured, they increased significantly in diameter and cell volume (Table 2). The mast cells in the bone marrow ranged in diameter from 3 to 13 µm. Measurements of cell diameters from electron micrographs in which the stage of maturation could be easily determined validated the data obtained by light microscopy. These results also showed that the majority of the resident mast cell population in bone marrow is composed of immature cells, with an appreciable number of mature mast cells and relatively few very immature cells.
|
The bone marrow-derived mast cells were also characterized as connective tissue-type mast cells by staining and PCR of the fractionated and unfractionated bone marrow. The bone marrow-derived mast cells stained positively with Toluidine Blue and were fluorescent with berberine sulfate (Fig 7A and Fig 7B), a marker for connective tissue-type mast cells. Moreover, messenger RNA was present for both the - and ß-subunits of the high-affinity IgE receptor, rat mast cell proteases 1 and 5, and carboxypeptidase A (Fig 8) in the total bone marrow population. When the mast cells were immunomagnetically isolated, the amount of message was enriched.
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In this study, using MAb AA4 and a panel of other antibodies combined with electron microscopy, it was possible to demonstrate that mast cells can completely differentiate in the bone marrow into connective tissue-type mast cells. The stages of maturation seen here for bone marrow-derived mast cells are in agreement with those reported for other granulocytes from the bone marrow (
Identification of mast cells in early stages of maturation, especially in vivo, has been limited (
Previous studies of mast cell maturation have relied on the presence of granules or granule content to identify mast cell progenitors. However, cytoplasmic granules are not present in great enough numbers during the very early stages of maturation to permit their use for mast cell identification. A number of previous investigations have attempted to use antibodies to identify immature mast cells, but their usefulness has been limited because these antibodies were not mast cell-specific and recognized other cell types in the preparation (RI and IgE. It is likely that these very immature cells represent committed rather than uncommitted mast cell progenitors, because even the most immature cells seen in this study already express Fc
RI. The presence of Fc
RI or IgE on the cell surface is a better indication that a progenitor cell has committed to differentiate than is the presence of cytoplasmic granules. The current study also indicates that the small lymphocyte-like cells previously reported to be mast cell precursors (
![]() |
Acknowledgments |
---|
Supported in part by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and by Fundação de Amparo á Pesquisa do Estado de São Paulo (FAPESP). Ana Cristina G. Grodzki is the recipient of a FAPESP fellowship and Luciana de Fátima C. de Mello and Maria Veronica D. Pastor are recipients of CAPES fellowships.
We wish to thank Maria Tereza Picinoto Maglia and José Augusto Maulin for technical assistance, Ana Carolina J. Dubas for help with the morphometry, Neal J. Hardegen and Alexandra Rosa Vieira Dias for assistance with the FACS analysis, and Linda Bowers for preparation of the micrographs.
Received for publication September 8, 2000; accepted September 13, 2000.
![]() |
Literature Cited |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Ahlstedt S, Haard J (1987) Age-dependent bone marrow mast cell maturation in specific pathogen-free rats. Int Arch Allergy Appl Immunol 84:359-362[Medline]
Ahlstedt S, Olaisson E (1986) Appearance of mast cells in bone marrow, peripheral blood and spleen of immunized rats. Int Arch Allergy Appl Immunol 80:122-126[Medline]
Ashman RI, Jarboe DL, Conrad DH, Huff TF (1991) The mast cell-committed progenitor: in vitro generation of committed progenitors from bone marrow. J Immunol 146:211-216
Bainton DF, Farquhar MG (1968) Differences in enzyme content of azurophil and specific granules of polymorphonuclear leukocytes. II. Cytochemistry and electron microscopy of bone marrow cells. J Cell Biol 39:299-317
Bainton DF, Farquhar MG (1970) Segregation and packaging of granule enzymes in eosinophilic leukocytes. J Cell Biol 45:54-73
Basciano LK, Berenstein EH, Kmak L, Siraganian RP (1986) Monoclonal antibodies that inhibit IgE binding. J Biol Chem 261:11823-11831
BentfeldBarker ME, Bainton DF (1980) Cytochemical localization of arylsulfatase B in rat basophils and mast cells. J Histochem Cytochem 28:1055-1061[Abstract]
Castells M (1997) Update on mast cells and mast cell precursors and hypersensitivity responses. Allergy Asthma Proc 18:287-292[Medline]
Chen X-J, Enerback L (1994) Application of an immunocolloid gold technique for the ultrastructural demonstration of IgE-receptor complexes on rat mast cells. APMIS 102:729-735[Medline]
Dines KC, Powell HC (1997) Mast cell interactions with the nervous system: relationship to mechanisms of disease. J Neuropathol Exp Neurol 56:627-640[Medline]
Dvorak AM (1991) Basophil and Mast Cell Degranulation and Recovery. New York, Plenum Press
Faraco CD, Vugman I, Siraganian RP, Jamur MC (1997) Immunocytochemical identification of immature rat peritoneal mast cells using a monoclonal antibody specific for rat mast cells. Acta Histochem 99:23-27[Medline]
Fawcett DW (1955) An experimental study of mast cell degranulation and regeneration. Anat Rec 121:29-43[Medline]
Forman JC (1993) Immunopharmacology of Mast Cells and Basophils. New York, Academic Press
Galli SJ (1993) New concepts about the mast cell. N Engl J Med 328:257-265
Galli S (2000) Mast Cells and Basophils. Curr Opin Hematol 7:32-39[Medline]
Ginsburg H, Lagunoff D (1967) The in vitro differentiation of mast cells. J Cell Biol 35:685-697
Guo N, Her GR, Reinhold VN, Brennan MJ, Siraganian RP, Ginsburg V (1989) Monoclonal antibody AA4, which inhibits binding of IgE to high affinity receptors on rat basophilic leukemia cells, bins to novel -galactosyl derivative of ganglioside GD1b. J Biol Chem 264:13267-13272
Huff TF, Lantz CS, Ryan J, Leftwich JA (1995) Mast cell-committed progenitors. In Kitamura Y, Yamamoto Y, Galli SJ, Greaves MW, eds. Biological and Molecular Aspects of Mast Cell and Basophil Differentiation and Function. New York, Raven Press, 105-117
Jamur MC, Faraco CD, Lunardi LO, Siraganian RP, Oliver C (1995) Microwave fixation improves antigenicity of glutaraldehyde-sensitive antigens while preserving ultrastructural detail. J Histochem Cytochem 43:307-311
Jamur MC, Grodzki ACG, Moreno AN, Swaim WD, Siraganian RP, Oliver C (1997) Immunomagnetic isolation of rat bone marrow-derived and peritoneal mast cells. J Histochem Cytochem 45:1715-1722
Jamur MC, Vugman I, Hand AR (1986) Ultrastructural and cytochemical studies of acid phosphatase and trimetaphosphatase in rat peritoneal mast cells developing in vivo. Cell Tissue Res 244:557-563[Medline]
Katz HB, LeBlanc PA, Russell SW (1983) Two classes of mouse mast cells delineated by monoclonal antibodies. Proc Natl Acad Sci USA 80:5916-5918[Abstract]
Kinzer CA, Keegan AD, Paul WE (1995) Identification of FceRIneg mast cells in mouse bone marrow cell cultures. Use of a monoclonal anti-p 161(antibody. J Exp Med 182):575-579
Kitamura Y, Go S, Hatanaka K (1978) Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52:447-452[Abstract]
Kitamura Y, Kasugai T, Arizono N, Matsuda H (1993) Development of mast cells and basophils: processes and regulation mechanisms. Am J Med Sci 306:185-191[Medline]
Kitamura Y, Sonoda T, Nakano T, Hayashi C, Asai H (1985) Differentiation process of connective tissue mast cells in living mice. Int Arch Allergy Appl Immunol 77:144-150[Medline]
Kitamura Y, Tsujimura T, Jippo T, Kasugai T, Kanakura Y (1995) Development of mast cells and basophils: role of c-kit receptor tyrosine kinase for development, survival and neoplast transformation of mast cells. In Kitamura Y, Yamamoto S, Galli SJ, Greaves MW, eds. Aspects of Mast Cell and Basophil Differentiation and Function. New York, Raven Press, 91-103
Lantz C, Huff TF (1995) Murine KIT+ lineage bone marrow progenitors express FceRII, but do not express FCeRI until mast cell granule formation. J Immunol 154:355
Mendonca VO, Vugman I, Jamur MC (1986) Maturation of adult rat peritoneal and mesenteric mast cells. A morphological and histofluorescence study. Cell Tissue Res 243:635-639[Medline]
Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77:1033-1079
Minoguchi K, Swaim WD, Berenstein EH, Siraganian RP (1994) Src family tyrosine kinase p53/56lyn, a serine kinase and Fc epsilon RI associate with alpha-galactosyl derivatives of ganglioside GD1b in rat basophilic leukemia RBL-2H3 cells. J Biol Chem 269:5249-5254
Nichols BA, Bainton DF (1973) Differentiation of human monocytes in bone marrow and blood. Sequential formation of two granule populations. Lab Invest 29:27-40[Medline]
Nichols BA, Bainton DF, Farquhar MG (1971) Differentiation of monocytes. Origin, nature, and fate of their azurophil granules. J Cell Biol 50:498-515
Odarjuk J, Rossow N, Karawajew L (1989) Investigation of mast cell differentiation in vivo by use of monoclonal antibodies. Int Arch Allergy Appl Immunol 90:261-266[Medline]
Oliver C, Sahara N, Kitani S, Robbins AR, Mertz LM, Siraganian RP (1992) Binding of monoclonal antibody AA4 to gangliosides on rat basophilic leukemia cells produces changes similar to those seen with Fce receptor activation. J Cell Biol 116:635-646[Abstract]
Reynolds ES (1963) The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208-212
Rimmer EF, Turberville C, Horton MA (1984) Human mast cells detected by monoclonal antibodies. J Clin Pathol 37:1249-1255[Abstract]
Rodewald H-R, Dessing M, Dvorak AM, Galli SJ (1996) Identification of a committed precursor for the mast cell lineage. Science 271:818-822[Abstract]
Secor VH, Secor WE, Gutekunst CA, Brown MA (2000) Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191:813-822
Siraganian RP (1988) Mast cells and basophils. In Gallin JJ, Goldstein IM, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. New York, Raven Press, 513-542
Smith TJ, Weis JH (1996) Mucosal T cells and mast cells share common adhesion receptors. Immunnol Today 17:60
Stephan V, Seibt A, Dukanovic D, Skasa M, Swaim WD, Berenstein EH, Siraganian RP, Wahn V (1997) Anti-ganglioside monoclonal antibody AA4 selectively inhibits IgE-induced signal transduction pathways in rat basophilic leukemia cells. Mol Immunol 34:227-235[Medline]
Swaim WD, Minoguchi K, Oliver C, Hamawy MM, Kihara H, Stephan V, Berenstein EH, Siraganian RP (1994) The anti-ganglioside monoclonal antibody AA4 induces protein tyrosine phosphorylations, but not degranulation, in rat basophilic leukemia cells. J Biol Chem 269:19466-19473
Thompson HL, Burnbelo PD, Metcalfe DD (1990) Regulation of adhesion of mouse bone marrow-derived mast cells to laminin. J Immunol 145:3425-3431
Valent P, Escribano L, Parwaresch RM, Schemmel V, Schwartz LB, Sotlar K, Sperr WR, Horny H-P (1999) Recent advances in mastocytosis research. Int Arch Allergy Immunol 120:1-7[Medline]
Yong LC, Watkins SG, Boland J (1979) The mast cell III: distribution and maturation in various organs of the young rat. Pathology 11:427-445[Medline]